66 related articles for article (PubMed ID: 19934332)
1. Confounding effects in "a six-gene signature predicting breast cancer lung metastasis": reply.
Driouch K; Bonin F; Sin S; Clairac G; Lidereau R
Cancer Res; 2009 Dec; 69(24):9507-11. PubMed ID: 19934332
[TBL] [Abstract][Full Text] [Related]
2. Confounding effects in "A six-gene signature predicting breast cancer lung metastasis".
Culhane AC; Quackenbush J
Cancer Res; 2009 Sep; 69(18):7480-5. PubMed ID: 19723662
[TBL] [Abstract][Full Text] [Related]
3. A six-gene signature predicting breast cancer lung metastasis.
Landemaine T; Jackson A; Bellahcène A; Rucci N; Sin S; Abad BM; Sierra A; Boudinet A; Guinebretière JM; Ricevuto E; Noguès C; Briffod M; Bièche I; Cherel P; Garcia T; Castronovo V; Teti A; Lidereau R; Driouch K
Cancer Res; 2008 Aug; 68(15):6092-9. PubMed ID: 18676831
[TBL] [Abstract][Full Text] [Related]
4. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse.
Harrell JC; Prat A; Parker JS; Fan C; He X; Carey L; Anders C; Ewend M; Perou CM
Breast Cancer Res Treat; 2012 Apr; 132(2):523-35. PubMed ID: 21671017
[TBL] [Abstract][Full Text] [Related]
5. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer.
Weigelt B; Hu Z; He X; Livasy C; Carey LA; Ewend MG; Glas AM; Perou CM; Van't Veer LJ
Cancer Res; 2005 Oct; 65(20):9155-8. PubMed ID: 16230372
[TBL] [Abstract][Full Text] [Related]
6. Subtypes of breast cancer show preferential site of relapse.
Smid M; Wang Y; Zhang Y; Sieuwerts AM; Yu J; Klijn JG; Foekens JA; Martens JW
Cancer Res; 2008 May; 68(9):3108-14. PubMed ID: 18451135
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
8. Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
Deeb KK; Michalowska AM; Yoon CY; Krummey SM; Hoenerhoff MJ; Kavanaugh C; Li MC; Demayo FJ; Linnoila I; Deng CX; Lee EY; Medina D; Shih JH; Green JE
Cancer Res; 2007 Sep; 67(17):8065-80. PubMed ID: 17804718
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer.
Tsang JY; Huang YH; Luo MH; Ni YB; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
Breast Cancer Res Treat; 2012 Nov; 136(2):407-17. PubMed ID: 23053657
[TBL] [Abstract][Full Text] [Related]
10. Specific chromatin landscapes and transcription factors couple breast cancer subtype with metastatic relapse to lung or brain.
Cai WL; Greer CB; Chen JF; Arnal-Estapé A; Cao J; Yan Q; Nguyen DX
BMC Med Genomics; 2020 Mar; 13(1):33. PubMed ID: 32143622
[TBL] [Abstract][Full Text] [Related]
11. Metastatic Organotropism: An Intrinsic Property of Breast Cancer Molecular Subtypes.
Wei S; Siegal GP
Adv Anat Pathol; 2017 Mar; 24(2):78-81. PubMed ID: 28098572
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer lung metastasis: Molecular biology and therapeutic implications.
Jin L; Han B; Siegel E; Cui Y; Giuliano A; Cui X
Cancer Biol Ther; 2018; 19(10):858-868. PubMed ID: 29580128
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer molecular subtypes respond differently to preoperative chemotherapy.
Rouzier R; Perou CM; Symmans WF; Ibrahim N; Cristofanilli M; Anderson K; Hess KR; Stec J; Ayers M; Wagner P; Morandi P; Fan C; Rabiul I; Ross JS; Hortobagyi GN; Pusztai L
Clin Cancer Res; 2005 Aug; 11(16):5678-85. PubMed ID: 16115903
[TBL] [Abstract][Full Text] [Related]
14. Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.
Del Casar JM; Martín A; García C; Corte MD; Alvarez A; Junquera S; González LO; Bongera M; García-Muñiz JL; Allende MT; Vizoso F
Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):147-52. PubMed ID: 18768247
[TBL] [Abstract][Full Text] [Related]
15. Molecular Basis of Lung Tropism of Metastasis.
Weidle UH; Birzele F; Kollmorgen G; Rüger R
Cancer Genomics Proteomics; 2016; 13(2):129-39. PubMed ID: 26912803
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
Huber KE; Carey LA; Wazer DE
Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic molecular classification of breast cancers based on gene expression profiling].
Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
[TBL] [Abstract][Full Text] [Related]
18. Gene expression patterns associated with p53 status in breast cancer.
Troester MA; Herschkowitz JI; Oh DS; He X; Hoadley KA; Barbier CS; Perou CM
BMC Cancer; 2006 Dec; 6():276. PubMed ID: 17150101
[TBL] [Abstract][Full Text] [Related]
19. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
[TBL] [Abstract][Full Text] [Related]
20. Nonfamilial breast cancer subtypes.
Ringnér M; Staaf J; Jönsson G
Methods Mol Biol; 2013; 973():279-95. PubMed ID: 23412797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
